Morgan Stanley Enochian Biosciences Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Morgan Stanley holds 356,658 shares of ENOB stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

356,658

Previous 454,428 21.51%

Holding current value

$1.64 Million

Previous $2.09 Million 21.53%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	N/A	-97,770 Reduced 21.51%	356,658 $1.64 Million
Q2 2024 Oct 17, 2024	BUY	N/A	79,111 Added 21.08%	454,428 $2.09 Million
Q2 2024 Aug 14, 2024	BUY	N/A	79,111 Added 21.08%	454,428 $2.09 Million
Q1 2024 Oct 17, 2024	SELL	N/A	-79,111 Reduced 17.41%	375,317 $1.73 Million
Q1 2024 Aug 16, 2024	BUY	N/A	12,339 Added 3.4%	375,317 $1.73 Million
Q1 2024 May 15, 2024	BUY	N/A	12,339 Added 3.4%	375,317 $1.73 Million
Q4 2023 Aug 16, 2024	SELL	$4.3 - $4.7 $393,235 - $429,815	-91,450 Reduced 20.12%	362,978 $1.67 Million
Q4 2023 Feb 13, 2024	BUY	$4.3 - $4.7 $985,835 - $1.08 Million	229,264 Added 171.46%	362,978 $1.67 Million
Q3 2023 Nov 15, 2023	BUY	$0.0 - $4.46 $0 - $389,594	87,353 Added 188.42%	133,714 $596,000
Q2 2023 Aug 14, 2023	SELL	$0.4 - $1.3 $11,709 - $38,054	-29,273 Reduced 38.7%	46,361 $26,000
Q1 2023 May 15, 2023	BUY	$0.91 - $1.31 $3,907 - $5,625	4,294 Added 6.02%	75,634 $69,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $2.13 $79,895 - $165,219	-77,568 Reduced 52.09%	71,340 $73,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.86 $32,793 - $55,169	19,290 Added 14.88%	148,908 $269,000
Q2 2022 Oct 27, 2022	BUY	$1.93 - $8.73 $147,998 - $669,442	76,683 Added 144.86%	129,618 $250,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $147,998 - $669,442	76,683 Added 144.86%	129,618 $250,000
Q1 2022 Oct 27, 2022	SELL	$4.42 - $9.0 $338,938 - $690,147	-76,683 Reduced 59.16%	52,935 $437,000
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $368,216 - $749,763	-83,307 Reduced 61.15%	52,935 $437,000
Q4 2021 Feb 14, 2022	SELL	$6.71 - $12.55 $3,267 - $6,111	-487 Reduced 0.36%	136,242 $994,000
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $623,484 - $1.08 Million	136,729 New	136,729 $920,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14.7M

Call Options Held

24K

Put Options Held

19.1K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account